Morgan, C. L., Durand, A. ., McCormack, T. ., Hughes, E. ., Berni, T. R., & Lahoz, R. . (2023). Risk of major adverse cardiovascular events associated with elevated low-density lipoprotein cholesterol in a population with atherosclerotic cardiovascular disease with and without type 2 diabetes: a UK database analysis using the CPRD. BMJ Open, 13, e064541. http://doi.org/10.1136/bmjopen-2022-064541
Cholesterol
Qureshi, N. ., Woods, B. ., de Faria, N. ., Goncalves, S. ., Cox, E. ., Bee, L. ., … Kai, J. . (2023). Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. Health Technol Assess, 27, 1–140. http://doi.org/10.3310/ctmd0148
Lai, H. T. M., Chang, K. ., Sharabiani, M. T. A., Valabhji, J. ., Gregg, E. W., Middleton, L. ., … Vamos, E. P. (2023). Twenty-year trajectories of cardio-metabolic factors among people with type 2 diabetes by dementia status in England: a retrospective cohort study. Eur J Epidemiol. http://doi.org/10.1007/s10654-023-00977-7
Weldegiorgis, M. ., & Woodward, M. . (2022). Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom. BMC Nephrol, 23, 312. http://doi.org/10.1186/s12882-022-02932-2